Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
OCUL compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name
OCUL
Ocular Therapeutix, Inc
Change
Mkt cap
Revenue
Revenue
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
vs
Compare
OCUL
Ocular Therapeutix, Inc
vs
LLY
ELI Lilly & Co
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Price
Desk
News
Calendar
Saved
Search
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
OCUL, solid
LLY, dashed
OCUL
Ocular Therapeutix, Inc
Change
6.61
▲
+2.80%
· post 6.60
Mkt cap
$1.4B
Revenue
$13M
Q2 FY26
Revenue
$52M
FY25
LLY
ELI Lilly & Co
Change
1,360.90
▼
−0.28%
· post 1,358.90
Closed
Nov 6 '26
Mkt cap
$1.2T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
vs
Compare
Closed
Nov 6 '26
OCUL
Ocular Therapeutix, Inc
vs
LLY
ELI Lilly & Co
6.61
▲
+2.80%
post 6.60
Price
1,360.90
▼
−0.28%
post 1,358.90
$1.4B
Mkt cap
$1.2T
Q2 FY26
$13M
Revenue
$24.4B
Q3 FY26
FY25
$52M
Revenue
$65.2B
FY25
Change
Change
OCUL
6.61
▲
+2.80%
vs
LLY
1,360.90
▼
−0.28%
Closed
Nov 6 '26